2019 annual financial data
Elicio Therapeutics 2019 Operating margin
Elicio Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -2,595.23%.
Operating income was -38,591,000 USD and net income was -40,658,000 USD.
Operating cash flow was -24,589,000 USD.
Get free Elicio Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,487,000 USD
- Operating income
- -38,591,000 USD
- Net income
- -40,658,000 USD
- Operating cash flow
- -24,589,000 USD